Snowball logo
logo
NBY

NovaBay Pharmaceuticals Inc

NBY β€’ NYSE MKT
$1.21$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
10.214.410.469.781-2.463
COGS
3.6896.6234.3713.30.14-
Gross Profit
6.5157.7816.0846.481(0.14)-
Operating Expenses & Income
Operating Income
(8.862)(14.42)(4.102)(5.839)(7.585)(4.68)
Total Operating Expenses
15.3822.210.1912.327.4457.819
R&D Expenses
0.0440.1740.0340.042--
Selling General & Admin Expenses
7.247.4895.4477.3797.5857.732
Earnings from Continuing Operations
Interest Expense
(3.038)(3.809)(1.694)(0.904)(0.277)(0.113)
Interest Income
4.6154.0850.020.096-0.077
Income Tax Expense
(4.615)(3.809)0.0351--3.454
Net Income
Net Income
(5.824)(10.61)(9.64)(7.223)(22.14)522.6
Supplemental
EBIT
(8.862)(7.68)(4.451)(6.306)(7.585)(4.643)
EBITDA
(8.743)(7.197)(4.095)(5.925)(7.445)(4.555)
In millions of USD, except % and values per 1 share